Colloidal aggregation: Mechanisms and implications

2007 ◽  
Vol 23 (08) ◽  
pp. 1241-1246 ◽  
Author(s):  
XIONG Hai-Ling ◽  
◽  
◽  
YUAN Yong-Zhi ◽  
LI Hang ◽  
...  

1997 ◽  
Vol 43 (12) ◽  
pp. 2384-2389 ◽  
Author(s):  
John C Thompson ◽  
Alan R Craig ◽  
Carol L Davey ◽  
David J Newman ◽  
Michele L Lonsdale ◽  
...  

Abstract We report kinetic studies on the reaction of a latex agglutination immunoassay used to quantify phenytoin in serum. In this assay, polystyrene particles with a covalently attached analog of phenytoin react with an antiphenytoin monoclonal antibody to form light-scattering aggregates, with the rate of this reaction being decreased by addition of phenytoin from sample. In the absence of free (sample) phenytoin, this reaction did not exhibit a maximum rate of agglutination in the presence of excess antibody, i.e., an equivalence point. Furthermore, agglutination was inhibitable by free phenytoin even when the latter was added after agglutination of particles with antibody had begun. Most significantly, the immunoagglutination proceeded in an identical fashion with monovalent F(ab) fragment. These data are consistent with low-affinity immunospecific particle–antibody complexation, which then induces colloidal aggregation, without requiring immunospecific bridging by antibody molecules. The described mechanism is not generalizable to all latex agglutination immunoassays, although disturbance of colloidal stability may be a component in most assays.


Langmuir ◽  
2003 ◽  
Vol 19 (26) ◽  
pp. 10710-10718 ◽  
Author(s):  
Hua Wu ◽  
Marco Lattuada ◽  
Peter Sandkühler ◽  
Jan Sefcik ◽  
Massimo Morbidelli

2006 ◽  
Vol 74 (4) ◽  
Author(s):  
Nicholas A. Licata ◽  
Alexei V. Tkachenko

Sign in / Sign up

Export Citation Format

Share Document